Automated cell counters are medical devices used to enumerate and analyze cells in a fluid, often blood or cell culture. Automated cell counters help evaluate overall health and detect diseases by counting the number of red blood cells, white blood cells, and platelets. Advantages of automated cell counters include speed, accuracy, and reproducibility compared to manual microscopy-based cell counting. The devices help researchers in drug discovery and development processes by studying cell proliferation rates and cell viability. The rising R&D investments in pharmaceutical and biotechnology industries have increased the demand for automated cell counters.
The Global Automated Cell Counters Market is estimated to be valued at US$ 3.75 Bn in 2024 and is expected to exhibit a CAGR of 7.0% over the forecast period 2023 to 2030.
Key Takeaways
Key players operating in the Automated Cell Counters market are Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, PerkinElmer Inc., Bio-Rad Laboratories, BD, Merck KGaA, Logos Biosystems, Corning Incorporated, Tecan.
The growing demand from industries like healthcare, biotechnology, pharmaceutical is a major factor driving the growth of automated cell counters market. The devices are widely utilized in diagnostic applications like complete blood count, white blood cell differential count.
Technological advancements like integration of artificial intelligence, development of portable cell counters suited for point-of-care-testing are expected to boost the adoption of automated cell counters. Integration of AI helps in automation of imaging and analysis process leading to more reliable results.
Market Trends
One of the key trends in the market is increasing adoption of flow cytometers. Flow cytometers are gaining popularity in research areas like immunology and stem cell research due to ability to phenotype cells based on multiple parameters simultaneously.
Another major trend is the incorporation of integrated automatic sample preparation modules. Integration of sample preparation steps like dilution, staining within the cell counters streamlines the overall workflow and eliminates manual sample preparation errors.
Market Opportunities
Rising focus on personalized medicine is expected to drive the utility of instruments in isolation and characterization of circulating tumor cells. Automated cell counters with high sensitivity are suitable for rare CTC counting.
Increasing healthcare expenditure in emerging economies of Asia Pacific and Latin America provides new growth avenues. Favorable government policies and initiatives towards strengthening healthcare infrastructure supports the demand.
Covid-19 Impact on Automated Cell Counters Market Growth
The outbreak of the COVID-19 pandemic has significantly impacted the growth of the automated cell counters market. Various lockdowns and social distancing norms imposed by governments across the globe have disrupted the supply chain and logistics of the market. The demand from end-use industries like hospitals, research laboratories, pharmaceutical companies reduced considerably. Major players witnessed supply shortages of components and declined production capabilities due to closed operations. However, high cases of COVID-19 infections also increased the demand for automated cell counters from diagnostic laboratories. Cell counting was crucial for a detailed diagnosis of immune response and severity of the virus. Researchers used cell counting techniques for vaccine development and drug discovery studies related to coronavirus. Post pandemic, market is anticipated to witness steady growth as production operations normalizes. To sustain long term growth, key players are focusing on offering easy to use, high throughput cell counters which reduces the risks of contagion.
Automated Cell Counters Market Geographical Regions
North America region holds the major share of automated cell counters market in terms of value. Availability of advanced healthcare infrastructure, high healthcare expenditure, presence of leading market players and research institutes drive the demand. The United States contributes significantly owing to large patient pool and favorable government funding for R&D activities. Europe accounts for the second largest market led by countries like Germany, United Kingdom and France. Rising prevalence of chronic diseases propels the adoption of cell counting systems for research studies in the region. Asia Pacific exhibits fastest growth and gaining prominence in cellular analysis. China stands as a lucrative market due to rising healthcare awareness, developing pharmaceutical sector and government initiatives to modernize diagnostic testing facilities.
Automated Cell Counters Market Fastest Growing Region
Asia Pacific exhibits fastest growth for the automated cell counters market in coming years. Significant rise in healthcare expenditure by governments aims to upgrade healthcare facilities with advanced cell analysis equipment. Emerging countries like India and China have huge growth potential owing to increasing investments in drug discovery, biosimilars development and biotechnology sectors. High disease burden, large patient pool generates demand for diagnostic testing which fuel cell counting applications. Supportive regulatory environment promotes domestic production and foreign investments by multinational players in the region. Development of regional distribution networks to remote areas and rural healthcare centers provides growth opportunities. Growing R&D collaborations between research laboratories and Asian pharmaceutical companies favor automation and high throughput solutions. Overall, improving access to healthcare services and medical advancements drives the Asia Pacific region to emerge as the fastest expanding market for automated cell counters.
sayabonde
21 Blog posts
